Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide component vaccine engineering: targeting the AIDS virus.

K B Cease1

  • 1Department of Internal Medicine, University of Michigan, Ann Arbor 48109-0724.

International Reviews of Immunology
|January 1, 1990
PubMed
Summary

Developing an effective AIDS vaccine is challenging because HIV infection doesn't create protective immunity. This review explores using engineered synthetic peptides for novel vaccine strategies, moving beyond traditional methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.

Cancer chemotherapy and pharmacology·2013
Same author

New insights and approaches regarding B- and T-cell epitopes in HIV vaccine design.

AIDS (London, England)·2000
Same author

A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein.

Vaccine·1999
Same author

Recovery and biological activity of filgrastim after injection through silicone rubber catheters.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1995
Same author

Optimized PCR using Vent polymerase.

PCR methods and applications·1994
Same author

Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development.

Annual review of immunology·1994

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Background:

  • Traditional vaccine approaches rely on natural infection-induced immunity, which is absent in HIV infection.
  • Live- or killed-virus vaccines may not be suitable for an effective and safe AIDS vaccine.
  • Novel strategies are needed for AIDS vaccine development.

Purpose of the Study:

  • To review the theory and practice of vaccine engineering using synthetic peptides.
  • To highlight progress in developing an AIDS vaccine using synthetic peptide components.

Main Methods:

  • Review of existing literature on synthetic peptide vaccine engineering.
  • Analysis of theoretical frameworks for vaccine design.
  • Examination of practical applications and advancements in the field.

Related Experiment Videos

Main Results:

  • Synthetic peptides offer powerful tools for vaccine research and optimization.
  • Engineering vaccines with synthetic peptides is a promising avenue for AIDS vaccine development.
  • Progress has been made in applying these methods towards an AIDS vaccine.

Conclusions:

  • Synthetic peptide-based vaccine engineering is a viable and advanced approach.
  • This strategy addresses limitations of traditional methods for challenging pathogens like HIV.
  • Continued research and development in synthetic peptide vaccines are crucial for future success.